Press Releases about Glaukos Corp
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://mms.businesswire.com/media/20240614638344/en/1258312/5/GlaukosRLogo_color_no_tagline.jpg)
![](https://mms.businesswire.com/media/20240528383262/en/1258312/5/GlaukosRLogo_color_no_tagline.jpg)
From Glaukos Corporation
Via Business Wire
![](https://mms.businesswire.com/media/20240501994978/en/1258312/5/GlaukosRLogo_color_no_tagline.jpg)
From Glaukos Corporation
Via Business Wire
![](https://mms.businesswire.com/media/20240416511785/en/1258312/5/GlaukosRLogo_color_no_tagline.jpg)
From Glaukos Corporation
Via Business Wire
![](https://mms.businesswire.com/media/20240410647328/en/1258312/5/GlaukosRLogo_color_no_tagline.jpg)
![](https://mms.businesswire.com/media/20240403177919/en/1258312/5/GlaukosRLogo_color_no_tagline.jpg)
![](https://mms.businesswire.com/media/20240401095985/en/1258312/5/GlaukosRLogo_color_no_tagline.jpg)
![](https://mms.businesswire.com/media/20240221978087/en/1258312/5/GlaukosRLogo_color_no_tagline.jpg)
Glaukos Announces Fourth Quarter and Full Year 2023 Financial Results
February 21, 2024
From Glaukos Corporation
Via Business Wire
![](https://mms.businesswire.com/media/20240131248268/en/1258312/5/GlaukosRLogo_color_no_tagline.jpg)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Glaukos Announces Participation in the J.P. Morgan Healthcare Conference
December 20, 2023
From Glaukos Corporation
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From Glaukos Corporation
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Glaukos Announces Participation in Stifel Healthcare Conference
November 07, 2023
From Glaukos Corporation
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Glaukos Announces Third Quarter 2023 Financial Results
November 01, 2023
From Glaukos Corporation
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From Glaukos Corporation
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Glaukos Announces Second Quarter 2023 Financial Results
August 02, 2023
From Glaukos Corporation
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From Glaukos Corporation
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From Glaukos Corporation
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
From Glaukos Corporation
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Glaukos Submits New Drug Application to U.S. FDA for iDose TR
February 27, 2023
From Glaukos Corporation
Via Business Wire
![](https://www.businesswire.com/images/bwlogo_extreme.png)
Glaukos Announces Fourth Quarter and Full Year 2022 Financial Results
February 22, 2023
From Glaukos Corporation
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.